Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid.
The purine metabolites hypoxanthine, xanthine and urate as well as creatinine were measured in cerebrospinal fluid (CSF) from two groups of patients and a reference sample group. In one of the patient groups lumbar CSF was collected in 2 ml portions until a total volume of 14 ml was withdrawn. Every second portion was analysed for its content of the metabolites in focus. In the other patient group both cisternal CSF and a fixed volume (20 ml) of lumbar CSF were obtained and analysed. An increase in concentration of hypoxanthine, xanthine and creatinine and a decrease in urate concentration was found in the successive CSF specimens. The mean individual increase in hypoxanthine concentration between the first and the last 2 ml portion was as high as 39.6%, while it was lower for xanthine, 21.5%, and creatinine, 6.7%. The decrease in urate concentration was 17.2%. The results from the other patient group were in good agreement with these findings. The concentrations in the cisternal CSF was 162% of that in lumbar CSF for hypoxanthine, 155% for xanthine, 123% for creatinine and 80% for urate. Mechanisms behind inter- and intraindividual differences in gradients are discussed.
Niklasson
F
F
Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
Hetta
J
J
Degrell
I
I
D001693:Biological Transport, Active; D002946:Cisterna Magna; D003404:Creatinine / Q000134:cerebrospinal fluid*; D003704:Dementia / Q000134:cerebrospinal fluid; D003863:Depression / Q000134:cerebrospinal fluid; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000134:cerebrospinal fluid*; D008161:Lumbosacral Region; D013115:Spinal Canal; D014527:Uric Acid / Q000134:cerebrospinal fluid*; D019820:Xanthine; D014970:Xanthines / Q000134:cerebrospinal fluid*
D007042:Hypoxanthines; D014970:Xanthines; D019820:Xanthine; D014527:Uric Acid; D019271:Hypoxanthine; D003404:Creatinine